A current model for predicting the risk of cardiovascular diseases in patients with type 2 diabetes mellitus

被引：0
|
作者：
Biryukova, E. V. [1 ]
机构：
[1] Moscow State Univ Med & Dent, Minist Hlth & Social Dev Russia, Moscow, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2012年 / 84卷 / 10期
关键词：
type 2 diabetes mellitus; ADVANCE trial; cardiovascular risk prediction scale; sugar-lowering therapy; BLOOD-GLUCOSE CONTROL; OUTCOMES; COMPLICATIONS; PREVALENCE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Type 2 diabetes mellitus (T2DM) is a severe progressive disease complicating the development of micro- and macrovascular complications that result in early disability, including that in able-bodied persons, a reduction in the patients' life, and its worse quality. The author discusses the new scale developed according to the results of the ADVANCE trial for predicting the cardiovascular risk in patients with T2DM which may be used widely in these patients to estimate the risk of cardiovascular events and as a tool to assist in determining the intensity of treatment. She considers current approaches to treating T2DM, by using the results of the ADVANCE trial.
引用
收藏
页码：98 / 102
页数：5
相关论文
共 50 条
  • [31] Dietary patterns and the risk of obesity, type 2 diabetes mellitus, cardiovascular diseases, asthma, and neurodegenerative diseases
    Medina-Remon, Alexander
    Kirwan, Richard
    Lamuela-Raventos, Rosa M.
    Estruch, Ramon
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2018, 58 (02) : 262 - 296
  • [32] Current concepts of cardiovascular diseases in diabetes mellitus
    Raza, JA
    Movahed, A
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2003, 89 (2-3) : 123 - 134
  • [33] Effect of Nigella sativa oil supplement on risk factors for cardiovascular diseases in patients with type 2 diabetes mellitus
    Kooshki, Akram
    Tofighiyan, Tahereh
    Rastgoo, Neda
    Rakhshani, Mohammad Hassan
    Miri, Mohammad
    PHYTOTHERAPY RESEARCH, 2020, 34 (10) : 2706 - 2711
  • [34] Risk of cardiovascular diseases associated with sulfonylurea as an add-on therapy to metformin in patients with type 2 diabetes mellitus
    Jeong, Hoon
    Choi, Eunmi
    Bang, Minyoung
    Kim, Bonggi
    Chung, Soo Youn
    Han, Soon Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 327 - 327
  • [35] Thiazolidinedione and cardiovascular risk in type 2 diabetes mellitus
    Yenny
    UNIVERSA MEDICINA, 2008, 27 (04) : 183 - 193
  • [36] Cardiovascular risk assessment in type 2 diabetes mellitus
    Ebaa Al-Ozairi
    R. Jan-Willem Middelbeek
    Edward S. Horton
    Current Diabetes Reports, 2006, 6 (5)
  • [37] Type 2 diabetes mellitus is not a cardiovascular risk equivalent
    Saely, CH
    Marte, T
    Aczel, S
    Langer, P
    Koch, L
    Schmid, F
    Drexel, H
    DIABETES, 2005, 54 : A182 - A183
  • [38] Cardiovascular risk in the spectrum of type 2 diabetes mellitus
    Ahmed, Intekhab
    Goldstein, Barry J.
    MOUNT SINAI JOURNAL OF MEDICINE, 2006, 73 (05): : 759 - 768
  • [39] Nutritional Aspects to Cardiovascular Diseases and Type 2 Diabetes Mellitus
    Billingsley, Hayley E.
    Heiston, Emily M.
    Bellissimo, Moriah P.
    Lavie, Carl J.
    Carbone, Salvatore
    CURRENT CARDIOLOGY REPORTS, 2024, 26 (03) : 73 - 81
  • [40] Development and validation of a risk nomogram model for predicting peripheral neuropathy in patients with type 2 diabetes mellitus
    Luo, Lingguang
    Long, Xinping
    Cheng, Cheng
    Xu, Qian
    Li, Jing
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
12345